SeaStar Medical Holding Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	0.14	-	-	-	-
Gross Profit	0.14	-	-	-	-
Selling, General & Admin	8.87	8.04	6.92	1.68	2.43
Research & Development	9.11	5.97	2.5	2.77	4.03
Other Operating Expenses	-	-	2.19	-	-
Operating Expenses	17.98	14.01	11.61	4.45	6.45
Operating Income	-17.84	-14.01	-11.61	-4.45	-6.45
Interest Expense	-0.24	-1.08	-0.63	-0.21	-3.31
Interest & Investment Income	0.1	-	-	-	-
Other Non Operating Income (Expenses)	-6.84	-5.99	0.05	0.06	-
EBT Excluding Unusual Items	-24.83	-21.08	-12.19	-4.6	-9.76
Gain (Loss) on Sale of Assets	-	-	-	-	0.07
Legal Settlements	-	-0.2	-	-	-
Other Unusual Items	-	-4.95	-	-	6.43
Pretax Income	-24.83	-26.23	-12.19	-4.6	-3.27
Income Tax Expense	0	-	0	-0	0.01
Net Income	-24.83	-26.23	-12.19	-4.6	-3.28
Net Income to Common	-24.83	-26.23	-12.19	-4.6	-3.28
Shares Outstanding (Basic)	4	1	0	0	-
Shares Outstanding (Diluted)	4	1	0	0	-
Shares Change (YoY)	331.88%	163.91%	13.43%	-	-
EPS (Basic)	-6.63	-30.26	-37.11	-15.87	-
EPS (Diluted)	-6.63	-30.26	-37.11	-15.87	-
Gross Margin	100.00%	-	-	-	-
Operating Margin	-13216.30%	-	-	-	-
Profit Margin	-18392.59%	-	-	-	-
EBIT	-17.84	-14.01	-11.61	-4.45	-6.45

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q